Sunteți pe pagina 1din 38

NUR 106: Course Schedule

• 1/24: Ch: 1,2


• 1/31: Ch: 3,7,8
• 2/7: Ch: 9, 10
• 2/14: Exam 1
• 2/21: Ch: 11,12, 14
• 2/28: Ch: 16,20,23
• 3/7: Ch: 25,29
• 3/14: Exam 2

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 4

NUR 106: Course Schedule Cont’d

• 3/21: Ch: 30,33


• 3/28: Ch: 34,35
• 4/4: No Classes
• 4/11: 27,36
• 4/18: Exam 3
• 4/25: Ch: 42, 46
• 5/2: Ch: 48
• 5/9: Last Day of Class- Exam 4

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 5

Chapter 1
Definitions, Names, Standards,
and Informational Sources

Foundations of Pharmacology

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 6

2
Types of Drug Names:

ƒ Chemical

ƒ Generic

ƒ Official

ƒ Trademark (brand)

ƒ Proprietary

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 7

CHEMICAL NAME

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 8

Sources of Drug Information


• American Drug Index
• American Hospital Formulary Service
• Drug Interaction Facts
• Drug Facts and Comparisons
• Handbook on Injectable Drugs
• Handbook of Nonprescription Drugs
• Martindale–The Complete Drug Reference
• Package inserts
• Natural Medicines Comprehensive Database
• Physicians’ Desk Reference (PDR)
• Nursing journals
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 9

3
Sources of Patient
Information

• United States Pharmacopeia Dispensing


Information (USPDI)

• Therapeutic Choices

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 10

U.S. Drug Legislation

• Federal Food, Drug, and Cosmetic Act (1938,


1952, 1962)

• Controlled Substances Act (1970)

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 11

Foundations of Pharmacology

• Drug review process

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 12

4
Chapter 2
Principles of Drug Action and
Drug Interactions

Mosby items and derived items © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 1

Basic principles

ƒ A strong understanding of the human body’s


processes are important to grasp drug actions
and drug interactions in the body

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.


Slide 14

Examples:

ƒ Antagonist—beta blockers

ƒ Agonist—epinephrine

ƒ Partial agonist—pentazocine

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.


Slide 15

5
Drug Stages After Administration

• Absorption

• Distribution

• Metabolism

• Excretion

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.


Slide 16

Categories of Drug Administration

• Enteral route: PO, Rectal, NG

• Parenteral route: subQ, IM, IV

• Percutaneous route: inhalation, sublingual,


topical

Half--life of Drugs
Half

• Factors modifying the


quantity of drug
reaching a site of action
after a single oral dose

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.


Slide 18

6
Terms used in relationship to
medications
• Desired action

• Side effects/ Adverse effects

• Allergic reactions: i.e. hives, urticaria

• Idiosyncratic reactions

• Carcinogenicity

• Teratogen
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Slide 19

Principles of Drug Action and


Drug Interactions
• Desired effect: when a drug enters a patient,
is absorbed and distributed, and produces the
expected response

• Adverse effect: “Any noxious, unintended and


undesired
d i d effect
ff t off a drug,
d which
hi h occurs att
doses used in humans for prophylaxis,
diagnosis or therapy” (World Health Organization)

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.


Slide 20

Principles of Drug Action and


Drug Interactions (cont’d)

• Drug interaction

ƒ Drug interactions represent 3% to 6% of


preventable in-hospital adverse drug reaction
cases

ƒ Drug interactions are a major component of


the number of hospital emergency department
visits and admissions

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.


Slide 21

7
Factors Influencing Drug Action

• Age
• Body weight
• Metabolic rate
• Illness
• Psycological aspects
• Tolerance
• Drug dependence
• Cumulative effect

Chapter 3
Drug Action Across the Life
Span

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 23

Drug Action Across the Life Span

• Age and gender affect drug therapy

• Gender-specific medicine

ƒ A developing
d l i science
i th
thatt studies
t di ththe
differences in the normal function of men and
women and how people of each sex perceive
and experience disease

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 24

8
Across The Life Span
Age Title of Stage
• <38 weeks • Premature
• 0-1 month • Newborn, neonate
• 1-24 months • Infant, baby
• 1-5 years • Young child
• 6-12 years • Older child
• 13-18 years • Adolescent
• 19-54 years • Adult
• 55-64 years • Older adult
• 65-74 years • Elderly
• 75-84 years • The aged
• 85+ years • The very old

Drug Action Across the Life Span

ƒ In nearly every body system, men and women


function differently

ƒ Men and women perceive and experience


disease differently

ƒ Fundamental questions remain about how


humans function and the effect of disease on
function

ƒ Pharmacogenetics
ƒ Polymorphisms
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 26

Drug Absorption: Age Considerations

• Special considerations for pediatric and older


adult patients

ƒ Differences in muscle mass, blood flow, and


inactivity affect medicines given
intramuscularly

ƒ Topical and transdermal administration differs


in the very young and the very old

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 27

9
Drug Absorption: Age Considerations

• Topical administration in infants is effective


because:

ƒ Outer layer of skin (stratum corneum) not fully


de eloped
developed

ƒ Skin more fully hydrated; plastic diaper


increases skin hydration

ƒ Inflammation (diaper rash) increases


absorption
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 28

Drug Absorption: Age Considerations

• Difficult to predict in geriatric patients

ƒ Dermal thickness decreases with age and may


enhance absorption

ƒ Drying, wrinkling, and decreased hair follicles


decrease absorption

ƒ Decreased cardiac output and diminishing


tissue perfusion also affect absorption

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 29

Drug Absorption: Age Considerations

• Gastrointestinal absorption influenced by:

ƒ Gastric pH

ƒ Gastric emptying time

ƒ Enzymatic activity

ƒ Blood flow of mucous lining and intestines

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 30

10
Drug Absorption: Gender Considerations
• Increased potential for toxicity and slower
absorption times in women

ƒ Empty solids more slowly

ƒ Have greater gastric acidity

ƒ Have lower gastric levels of alcohol


dehydrogenase needed to metabolize alcohols

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 31

Drug Distribution
• Depends on pH, body water concentrations,
presence and quantity of fat tissue, protein
binding, cardiac output, and regional blood
flow

• Infants
I f t have
h larger
l volume
l off water
t content
t t
and require higher dose

• With age, total body water decreases and fat


increases

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 32

Drug Distribution

• Highly fat-soluble drugs take longer to act


and accumulate in fat tissues, increasing
potential for toxicity

• Protein
P i bi
binding
di
ƒ Drugs that are relatively insoluble are
transported in circulation by binding to
plasma proteins

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 33

11
Drug Distribution

ƒ Age considerations
• Some drugs have lower protein binding in
neonates and require larger loading dose
• Albumin levels decrease with age

ƒ Gender considerations
• Some differences between men and
women in globulin proteins

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 34

Drug Metabolism
• Drug metabolism

ƒ Process by which the body inactivates


medicine

ƒ Affected by genes, diet, age & maturity of


enzyme systems

ƒ Liver weight and hepatic blood flow decrease


with age

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 35

Routes of Medication Excretion

Primary Routes
• Renal tubules: into the urine
• GI tract: through feces

Minor Routes
• Evaporation: through skin
• Exhalation: from the lungs
• Secretion: in saliva & breast milk

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc . Slide 36

12
Drug Excretion

• Metabolites of drugs (and sometimes the


drug itself) eventually excreted

• Preterm infant has 15% of adult renal


capacity; fully functional by 9 to 12 months

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 37

Drug Excretion (cont’d)

• Decreased renal function with age

• No prediction of renal function can be based


solelyy on age
g because of wide individual
variation in changes

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 38

Percentages of Body Water

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 39

13
Therapeutic Drug Monitoring

• Entails measurement of a drug’s


concentration in biologic fluids to correlate the
dosage administered and the level of
medicine in the body with the pharmacologic
response

• Timing of drug’s administration and collection


of specimen are crucial to accurate
interpretation

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 40

Use of Monitoring Parameters

• Before administering medicine, assess


expected therapeutic actions, side effects,
reportable adverse effects, probable drug
interactions

• Monitoring parameters related to patient’s


age

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 41

Monitoring Parameters:
Pediatric Patients

• Infants and young children more susceptible


to dehydration

• Weight
g variation affects dosage
g

• Aspirin never to be administered to children

• Allergic reactions occur rapidly in children,


most commonly to antibiotics

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 42

14
Monitoring Parameters: Older Adult Patients

• Factors that place older patient at risk:

ƒ Reduced renal and hepatic function

ƒ Chronic illness

ƒ Polypharmacy—multiple-drug therapy required


by chronic illness

ƒ A greater likelihood of malnourishment due to


polypharmacy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 43

Monitoring Parameters: Older Adult Patients

• Drug therapy

ƒ Take thorough drug history and nutritional


assessment
ƒ Determine whether new symptoms
y p have
been induced by existing medicines
ƒ Gradually taper dosage when discontinuing
drug
ƒ Start at one third to one half normal dosage
when initiating therapy; gradually increase
ƒ Review regimen periodically

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 44

Potentially Inappropriate Medications


for Older Adult Patients

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 45

15
Use of Monitoring
Parameters: Pregnant Women
• Avoid drugs if at all possible

• When taking woman’s history, be alert to


possibility of pregnancy

• Instruct
I patient
i to avoid
id d
drugs, alcohol,
l h l
tobacco

• Try nonpharmacologic treatments before


using medicines

• Avoid herbal medicines


Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 46

Drugs Known to Be
Teratogenic

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 47

Use of Monitoring Parameters:


Breast--Feeding Patients
Breast

• Some drugs are known to enter breast milk


and harm nursing infant

• Discuss all medications with physician

• Take medicine immediately after breast-


feeding or just before infant’s longest
sleeping period

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 48

16
Chapter 7
Principles of Medication
Administration

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 49

Legal and Ethical


Considerations
• Standards of care: developed by the state’s
nurse practice act, state and federal law,
JCAHO, professional organizations
• Before administering medication, nurse must
have:
ƒ Currentt license
C li tto practice
ti
ƒ Clear policy statement authorizing the act
ƒ Signed medication order
ƒ Understanding of rationale for drug use
ƒ Understanding of drug action, dosing, dilution,
route and rate of administration, side effects,
adverse effects to report, contraindications
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 50

Contents of Patient Charts

• Summary sheet
• Consent forms
• Physician’s order form
• History and physical exam form
• P
Progress notes
t
• Critical pathways
• Nurses’ notes
• Laboratory tests record

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 51

17
Contents of Patient Charts
• Graphic record
• Flow sheets
• Consultation reports
• Other diagnostic reports
• Medication administration record (MAR) or
medication profile
• PRN or unscheduled medication record
• Case management
• Patient education record

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 52

Legal and Ethical


Considerations
• Standards of care: developed by the state’s
nurse practice act, state and federal law,
JCAHO, professional organizations
• Before administering medication, nurse must
have:
ƒ Currentt license
C li tto practice
ti
ƒ Clear policy statement authorizing the act
ƒ Signed medication order
ƒ Understanding of rationale for drug use
ƒ Understanding of drug action, dosing, dilution,
route and rate of administration, side effects,
adverse effects to report, contraindications
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 53

Contents of Patient Charts


• Summary sheet
• Consent forms
• Physician’s order form
• History and physical exam form
• Progress notes
• Critical pathways
• Nurses’ notes
• Laboratory tests record

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 54

18
Contents of Patient Charts
(cont’d)
• Graphic record
• Flow sheets
• Consultation reports
• Other diagnostic reports
• Medication administration record (MAR) or
medication profile
• PRN or unscheduled medication record
• Case management
• Patient education record

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 55

The Kardex

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 56

Drug Distribution Systems

• Floor or ward stock system

• Individual prescription order system

• Computer-controlled
C t t ll d di
dispensing
i system
t

• Unit dose system

• Long-term care unit dose system

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 57

19
Narcotic Control Systems

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 58

The Drug Order


• Stat order

• Standing order

• Renewal order

• PRN order

• Verbal orders

• Electronic transmission of patient orders


Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 59

Medication Errors
• Prescribing errors

• Transcription errors

• Dispensing errors

• Administration errors

• Monitoring errors

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 60

20
Nurse Responsibilities
• Verification
ƒ Nurse makes professional judgment regarding
acceptability and safety of the drug order,
including type of drug, dose and dose
preparation, therapeutic intent, route, potential
allergic reactions, or contraindications

• Transcription
ƒ Nurse is responsible for verification of orders
transcribed by others

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 61

The Six Rights


• 1. Right drug
ƒ Compare exact spelling and concentration of
drug with medication card and drug container;
drug label should be read three times

• 2. Right
g time
ƒ Standard abbreviations
ƒ Standardized administration times
ƒ Maintenance of consistent blood levels
ƒ Maximum drug absorption
ƒ Diagnostic testing
ƒ PRN medications

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 62

The Six Rights (cont’d)


• 3. Right dose
ƒ Abnormal hepatic or renal function
ƒ Nausea and vomiting
ƒ Accurate dose forms
ƒ Accurate calculations
ƒ Correct measuring devices

• 4. Right patient
ƒ Bracelet checking
ƒ Pediatric and older adult patients

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 63

21
The Six Rights
• 5. Right route
ƒ IV route
ƒ Intramuscular route
ƒ Intravenous route
ƒ Subcutaneous route
ƒ Oral route

• 6. Right documentation
ƒ Safety/ethical considerations
ƒ Legal considerations
ƒ Always include date/time, drug name, dose,
route, site of administration
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 64

Special Documentation
Circumstances

• Patient refuses medication


ƒ Thoroughly record incident and reason for
refusal in nurses’ notes
ƒ Notify physician

• Medication error occurs


ƒ Notify physician
ƒ Complete incident report

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 65

Chapter 8
Percutaneous Administration

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 66

22
Percutaneous Administration
• Application of medications to the skin or
mucous membranes for absorption

• Includes:
ƒ Topical application of ointments, creams,
lotions or powders to the skin
lotions,
ƒ Inhalation of aerosolized liquids or gases
ƒ Installation of solutions into the mucous
membranes of the mouth, eye, ear, nose, or
vagina

• Always follow the six rights of drug


administration
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 67

Percutaneous Administration

• Premedication assessment and explanation


• Patient teaching
ƒ Hygiene requirements
ƒ Proper application techniques and timing
ƒ Cautions particular to drug or drug
administration
ƒ Side effects
ƒ When to contact physician

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 68

Percutaneous Administration

• Documentation

ƒ Date, time, drug, dosage, route

ƒ Record ongoing assessment data, including


signs of adverse drug effects

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 69

23
Creams, Lotions, Ointments
• Wash hands, put on gloves, position patient

• Clean area

• Wear gloves

• Shake lotion bottle; use tongue blade to


remove desired amount of ointment or cream
from container

• Use dressings according to orders

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 70

Patch Testing
• Method to identify sensitivity to contact
materials (soaps, pollen, dyes)

• Allergens on patch placed in contact with


back, arms, or thighs

• Patch left in place for 48 hours

• Site aired for 15 minutes, then read

• Emergency equipment must be available in


case of anaphylactic response
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 71

Patch Testing
• Wash hands, put on gloves,position patient

• Clean the area

• Wear g
gloves

• Apply dose-measuring applicator paper

• Do not rub in ointment

• Cover area with plastic wrap


Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 72

24
Transdermal Drug Delivery
• Disk or patch providing controlled release of
medication

• Wash hands,put on gloves,position patient

• Apply topical disk or patch

• Application frequency depends on drug

• Wash hands after application

• Label disk with time, date, nurse initials


Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 73

Topical Powders
• Particles of medication in a talc base

• Wash hands, put on gloves

• Position the patient

• Wash and thoroughly dry area

• Apply powder, smooth over area for even


coverage

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 74

Sublingual and Buccal


Tablets
• Sublingual tablets: placed under the tongue

• Buccal tablets: held in the buccal cavity

• Advantage: rapid absorption and onset of


action

• Action is usually systemic, rather than


localized to the mouth

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 75

25
Eye Drops, Ointments, and
Disks
• OD (right eye), OS (left eye), OU (both eyes)

• Wash hands, put on gloves,position patient

• Inspect affected eye

• Expose lower conjunctival sac

• Approach eye from below

• Never touch eye with dropper, tube


Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 76

Ear Drops
• Ensure ear is clear of wax

• Warm medication to room temperature

• Younger than age 3: pull earlobe downward


and back

• Older than age 3 and adults: pull earlobe


upward and back

• Patient should remain on side for a few


minutes
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 77

Nose Drops, Nasal Spray


• Patient should blow nose gently
• Nose drops
ƒ Position patient lying down with head hanging
back
• Nose spray
ƒ Patient is upright
ƒ Block one nostril
ƒ Shake bottle and insert tip into nostril
ƒ Spray while patient inhales

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 78

26
Nebulizers and Inhalers
• Nebulizers
ƒ Prepare medication and fill nebulizer
ƒ Patient exhales
ƒ Put nebulizer in mouth; do not seal completely
ƒ Patient inhales
• Metered-dose inhalers
ƒ Follow instructions on inhaler
• Dry powder inhalers
ƒ Follow instructions on inhaler

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 79

Vaginal Medications
• Wash hands, put on gloves
• Fill applicator
• Place patient in lithotomy position, elevate
hips with pillow
• Spread
p labia and insert applicator
pp or
suppository

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 80

Chapter 9
Enteral Administration

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 81

27
Administration of Oral
Medications
• Enteral is direct administration to the GI tract
• Most drugs are available in oral dose forms:
ƒ Capsules—small, cylindrical gelatin containers
used to administer unpleasant tasting
medications; timed-release capsules (provides a
gradual and continuous release of the drug);
lozenges or troches—flat disks in a flavored base
ƒ Tablets (powdered drugs that have been
compressed)
ƒ Elixirs—drugs dissolved in water and alcohol
ƒ Emulsions of water-in-oil or oil-in-water
ƒ Liquid suspensions and syrups

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 82

Administration of Oral
Medications
• Common methods used to administer oral
medications

ƒ Unit dose packaging providing a single dose


ƒ Soufflé cups
ƒ Medicine cups
ƒ Medicine droppers
ƒ Teaspoons
ƒ Oral syringes: plastic syringes calibrated and used
to measure liquid medications
ƒ Nipples with additional holes, used for infants

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 83

Administration of Solid-
Solid-Form
Oral Medications
• Two techniques for administering medications:
the medication card and unit dose distribution

• Perform premedication assessment in all cases

• All techniques follow FIVE RIGHTS procedure:


ƒ RIGHT patient
ƒ RIGHT drug
ƒ RIGHT route of administration
ƒ RIGHT dose
ƒ RIGHT time of administration

• ALWAYS check or recheck the FIVE RIGHTS


Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 84

28
Administration of Solid-
Solid-Form
Oral Medications

• General principles apply to all distribution systems


ƒ Give the most important medications first
ƒ Do not touch the medication with your hands
ƒ Encourage liquid intake to ensure swallowing
ƒ Remain with patient while medication is taken; DO
NOT leave the medication at bedside unless an order
to do so exists
ƒ Discard the medication container

• Provide complete documentation of administration


and responses to therapy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 85

Administration of Solid-
Solid-Form
Oral Medications
• Documentation of medication administration and
responses to drug therapy is called the “Sixth Right”

• General principles apply to all medication


administration
ƒ Chart date, time, drug name, dosage, and route of
administration
d i i t ti
ƒ Regularly record patient assessments to evaluate
therapeutic effectiveness
ƒ Chart and report any sign of adverse drug effects

• Perform and validate essential education about drug


therapy and other aspects of intervention for the
individual

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 86

Administration of Liquid-
Liquid-Form
Oral Medications
• General procedures are the same as with
solid-form oral medications

• Perform premedication assessment in all


cases

• All techniques follow the FIVE RIGHTS


procedure

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 87

29
Administration of Liquid-
Liquid-Form
Oral Medications (cont’d)
• General principles for infants, children, and
adults
ƒ Give adults and children the most important
medications first
ƒ NEVER dilute medications without specific
orders. DO NOT leave a medication at the
bedside without an order to do so
ƒ Check an infant’s ID and be certain the infant
is alert

• Provide complete documentation of


administration and responses to therapy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 88

Administration of Liquid-
Liquid-Form
Oral Medications
• Measuring techniques vary according to
receptacle used

• With a measuring cup:


ƒ Cover label to prevent smearing; place
fingernail at exact level on measuring cup;
read the volume at the level of meniscus—see
Figure 9-13. Recheck FIVE RIGHTS.

• With an oral syringe:


ƒ Select syringe of appropriate size. Draw up
prescribed volume of medication from bottle or
medicine cup

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 89

Administration of Medications
by Nasogastric Tube
• Drugs are administered via NG tube for
specific patients, using a liquid form
whenever possible. Remember:
ƒ Always flush the tube before and after
administration
ƒ Perform p
premedication assessment
ƒ Assemble equipment before administration

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 90

30
Administration of Medications
by Nasogastric Tube (cont’d)

• Prepare doses as for administration of solid-


form or liquid-liquid form oral medications
• Three methods for checking NG tube location
• Follow procedure for administering
medication
di i
• DO NOT attach suction for 30+ minutes
• Provide complete documentation of
administration and responses to therapy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 91

Administration of Enteral Feedings via


Gastrostomy of Jejunostomy Tube
• Enteral formulas are in several mixtures to
meet individual needs
• Assemble equipment beforehand
• Prescribed enteral formula should be
checked

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 92

Administration of Enteral Feedings Via


Gastrostomy or Jejunostomy Tube (cont’d)

• Formula should be fully labeled


• Discard unused formula every 24 hours
• Follow the guidelines specific for patients
receiving general nutrition via intermittent or
continuous feedings
• Follow FIVE RIGHTS
ƒ RIGHT patient, RIGHT drug (formula), RIGHT
route of administration, RIGHT dose (amount,
dilution, strength), RIGHT time

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 93

31
Administration of Enteral Feedings via
Gastrostomy or Jejunostomy Tube (cont’d)

• Verify tube placement and initiate feeding


• Flush, then clamp tube
• Proceed with tube feeding technique
ƒ Intermittent: use Toomey
y syringe
y g
ƒ Continuous: use disposable feeding container
and enough formula for a 4-hour period
• Provide complete documentation of
administration and responses to therapy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 94

Administration of Rectal
Suppositories
• Suppositories are solid medication designed
to dissolve inside a body orifice
• Equipment is simple:
ƒ Finger cot or disposable glove
ƒ Water-soluble lubricant
ƒ Prescribed
P ib d suppository
it
• Perform standard premedication assessment

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 95

Administration of Rectal
Suppositories (cont’d)

• Technique begins with FIVE RIGHTS


ƒ Explain procedure and check pertinent
parameters
ƒ Patient bends uppermost leg
ƒ Apply
A l llubricant
bi t tto titip off suppository.
it Pl
Place
suppository about 1 inch beyond orifice, past
internal sphincter
• Provide complete documentation of
administration and responses to therapy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 96

32
Administration of a Disposable
Enema
• The dose form will be a prepackaged,
disposable-type enema solution
• Equipment is simple
• Perform standard premedication assessment

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 97

Administration of a Disposable
Enema (cont’d)

• Technique begins with FIVE RIGHTS


ƒ Explain procedure and check pertinent
parameters
• Time of last defecation
ƒ Patient
P ti t bends
b d uppermostt leg l
ƒ Apply lubricant to rectal tube
ƒ Insert lubricated tube and insert solution
• Provide complete documentation of
administration and responses to therapy

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 98

Parenteral Administration
• Parenteral means drug administration by any
route other than the gastrointestinal tract

• Parenteral route
ƒ Intradermal
ƒ Subcutaneous
ƒ Intramuscular (IM)
ƒ Intravenous (IV)

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 99

33
Chapter 10
Parenteral Administration:
Safe Preparation of Parenteral
Medications

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 100

Equipment Used in Parenteral


Administration
• The syringe has three parts: barrel, plunger,
and tip
• Syringes are calibrated in minims, milliliters,
or cubic centimeters
• Tuberculin syringes are used to measure
smallll volumes
l off medication
di ti accurately
t l

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 101

Equipment Used in Parenteral


Administration (cont’d)

• The insulin syringe has a special scale for


measuring insulin

• In the United States, insulin is manufactured


in U-100 concentration
ƒ The U-100 syringe holds 100 units of insulin
per milliliter
ƒ Low-dose insulin syringes are used for
patients receiving 50 units or less of U-100
insulin

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 102

34
Equipment Used in Parenteral
Administration (cont’d)

• Prefilled syringes are disposable and have a


premeasured amount of medication

ƒ Advantages: time saved in preparation, less


chance
h off contamination
t i ti

ƒ Disadvantages: additional expense, different


holders for different cartridges, volume of
second medication limited

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 103

Equipment Used in Parenteral


Administration (cont’d)

• The needle has three parts:


ƒ Hub
ƒ Shaft
ƒ Beveled tip

• The needle gauge is the diameter of the hole


through the needle

• Needle selection depends on age of patient,


and site (subcutaneous, IM, or IV)—see
Table 10-1
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 104

Equipment Used in Parenteral


Administration (cont’d)

• Major safety development: needleless


systems

ƒ Provide an alternative to needles for routine


procedures, reducing the risk of needlesticks
with contaminated sharps

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 105

35
Equipment Used in Parenteral
Administration (cont’d)

• Other safety devices have been developed

ƒ BD Safety-Lok Syringe
ƒ BD SafetyGlide Shielding Hypodermic Needle
ƒ BD SafetyGlide Syringe Tiny Needle Technology
ƒ BD Integra Syringe

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 106

Parenteral Dose Forms


• Ampules
ƒ Glass containers usually containing a single
dose

• Vials
ƒ Glass containers that contain one or more
doses

• Mix-O-Vials
ƒ Glass containers with one dose, two
compartments

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 107

Preparation of Parenteral
Medication

• Equipment needed for preparation of


parenteral medications

ƒ Drug in sterile, sealed container


ƒ Syringe of the correct volume
ƒ Needles of the correct gauge and length
ƒ Needleless access device
ƒ Antiseptic swab
ƒ MAR or medication profile

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 108

36
Preparation of Parenteral
Medication

• Techniques for preparing all parenteral


medications

ƒ Use the five RIGHTS: Right Patient, Right


Drug, Ri
D Right
ht R
Route
t off Ad
Administration,
i i t ti Ri
Right
ht
Dose (Amount and Concentration), Right Time
of Administration

ƒ Check the drug dose form ordered against the


source you are holding

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 109

Preparing a Medication from


an Ampule

• Move solution to the bottom of the ampule

• Cover the ampule neck with a sterile gauze


pledget or antiseptic swab while breaking off
top

• Using an aspiration needle, withdraw


medication from ampule

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 110

Preparing a Medication from


an Ampule

• Remove the needle from the ampule and


point the needle vertically

• Pull back the plunger. Replace the aspiration


needle with a new sterile needle

• Push plunger until medication is at tip of


needle

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 111

37
Preparing a Medication from a
Vial

• Cleanse the top of the vial of diluent

• Pull plunger of syringe to fill with an amount


of air equal to the volume of the solution to be
withdrawn

• Insert the needle or needleless access device


through the diaphragm, inject air

• Withdraw the measured volume of diluent


required to reconstitute the powdered drug
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 112

Preparing a Medication from a Vial

• Tap the vial of powdered drug to break up


caked powder; cleanse the rubber diaphragm
with swab

• Insert the needle or needleless access device


iin th
the di
diaphragm
h and
d iinject
j t th
the dil
diluentt iin th
the
powder

• Mix thoroughly to dissolve powder

• Change needle to correct gauge and length


to administer the medication to the patient
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 113

Preparing a Medication from a


Mix--O-Vial
Mix
• Tap the container a few times to break up the
caked powder

• Remove the plastic lid protector

• Push firmly on the diaphragm-plunger

• Mix thoroughly

• Cleanse the rubber diaphragm and remove


drug using syringe to administer to patient
Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 114

38
Special Preparations

• Occasionally two medications may be drawn


into the same syringe for a single injection

• Medications
M di ti need
d tto b
be prepared
d ffor use iin
the sterile field during a surgical procedure

Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Slide 115

39

S-ar putea să vă placă și